These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 2302378)

  • 81. Are myotonias and periodic paralyses associated with susceptibility to malignant hyperthermia?
    Lehmann-Horn F; Iaizzo PA
    Br J Anaesth; 1990 Nov; 65(5):692-7. PubMed ID: 2248848
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Characterization of swine susceptible to malignant hyperthermia by in vivo, in vitro and post-mortem techniques.
    Seewald MJ; Eichinger HM; Lehmann-Horn F; Iaizzo PA
    Acta Anaesthesiol Scand; 1991 May; 35(4):345-9. PubMed ID: 1853698
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Investigation of malignant hyperthermia in Denmark and Sweden.
    Ording H; Ranklev E; Fletcher R
    Br J Anaesth; 1984 Nov; 56(11):1183-90. PubMed ID: 6487440
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Evaluation of creatinine phosphokinase in screening patients for malignant hyperpyrexia.
    Ellis FR; Clarke IM; Modgill M; Currie S; Harriman DG
    Br Med J; 1975 Aug; 3(5982):511-3. PubMed ID: 1164612
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Diagnosis of susceptibility to malignant hyperthermia in man.
    Ording H
    Br J Anaesth; 1988 Feb; 60(3):287-302. PubMed ID: 3279989
    [No Abstract]   [Full Text] [Related]  

  • 86. Serum creatine kinase level as a screening test for susceptibility to malignant hyperthermia.
    Paasuke RT; Brownell AK
    JAMA; 1986 Feb; 255(6):769-71. PubMed ID: 3944979
    [TBL] [Abstract][Full Text] [Related]  

  • 87. No relationship between fiber type and halothane contracture test results in malignant hyperthermia.
    Heiman-Patterson T; Fletcher JE; Rosenberg H; Tahmoush AJ
    Anesthesiology; 1987 Jul; 67(1):82-4. PubMed ID: 2440353
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Management of patients susceptible to malignant hyperthermia: A surgeon's perspective.
    Carlson KJ; Sun SA; Swan C; Koenig M; Derkay CS
    Int J Pediatr Otorhinolaryngol; 2022 Aug; 159():111187. PubMed ID: 35660936
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Comparison of European and North American malignant hyperthermia diagnostic protocol outcomes for use in genetic studies.
    Fletcher JE; Rosenberg H; Aggarwal M
    Anesthesiology; 1999 Mar; 90(3):654-61. PubMed ID: 10078664
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Comparison between the European and North American protocols for diagnosis of malignant hyperthermia susceptibility in humans.
    Islander G; Twetman ER
    Anesth Analg; 1999 May; 88(5):1155-60. PubMed ID: 10320187
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Detection of peranesthetic malignant hyperthermia by muscle contracture tests and NMR spectroscopy].
    Kozak-Reiss G; Gascard JP; Redouane-Bénichou K
    Ann Fr Anesth Reanim; 1986; 5(6):584-9. PubMed ID: 3826791
    [TBL] [Abstract][Full Text] [Related]  

  • 92. [Definition of a diagnostic score of malignant hyperthermia using P-31 magnetic resonance spectroscopy].
    Bendahan D; Kozak-Ribbens G; Confort-Gouny S; Cozzone PJ
    Ann Fr Anesth Reanim; 1996; 15(5):583-8. PubMed ID: 9033751
    [TBL] [Abstract][Full Text] [Related]  

  • 93. In vitro effect of ephedrine, adrenaline, noradrenaline and isoprenaline on halothane-induced contractures in skeletal muscle from patients potentially susceptible to malignant hyperthermia.
    Urwyler A; Censier K; Seeberger MD; Rothenbühler JM; Kaufmann MA; Drewe J
    Br J Anaesth; 1993 Jan; 70(1):76-9. PubMed ID: 8431339
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Importance of fasting in the lymphocyte calcium test for malignant hyperthermia.
    Fletcher JE; Conner GE; Allen GC; Huggins FJ; Rosenberg H
    Acta Anaesthesiol Scand; 1990 Nov; 34(8):636-9. PubMed ID: 2275324
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The in-vitro caffeine contracture test: influence of the muscle histochemical profile on test results.
    Brownell AK; Szabo M
    Can Anaesth Soc J; 1982 May; 29(3):218-21. PubMed ID: 7074401
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Malignant hyperthermia--diagnostic dilemma: false-negative contracture responses with halothane and caffeine alone.
    Wedel DJ; Nelson TE
    Anesth Analg; 1994 Apr; 78(4):787-92. PubMed ID: 8135402
    [No Abstract]   [Full Text] [Related]  

  • 97. Effect of halothane equilibration kinetics on in vitro muscle contractures for malignant hyperthermia screening.
    Urwyler A; Funk B; Censier K; Drewe J
    Acta Anaesthesiol Scand; 1992 Feb; 36(2):115-8. PubMed ID: 1549929
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Effect of temperature variation (22 degrees C-44 degrees C) on halothane and caffeine contracture testing in normal humans.
    Antognini JF; Gronert GA
    Acta Anaesthesiol Scand; 1997 May; 41(5):639-42. PubMed ID: 9181168
    [TBL] [Abstract][Full Text] [Related]  

  • 99. [Prospective evaluation of a nuclear magnetic resonance score in the screening of malignant hyperthermia susceptibility. Initial results].
    Payen JF; Bosson JL; Stieglitz P
    Ann Fr Anesth Reanim; 1996; 15(1):47-48. PubMed ID: 8729310
    [TBL] [Abstract][Full Text] [Related]  

  • 100. In vitro diagnosis of malignant hyperthermia: influence of electrical stimulation on the contracture response to caffeine.
    Heytens L; Martin JJ; Bossaert LL
    Br J Anaesth; 1992 Jul; 69(1):87-91. PubMed ID: 1637610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.